C WorldWide Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

C WorldWide Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-182,301	Closed	-$1.41M	–	130
2016 Q3	$1.41M	Sell	182,301 -40,680	-18%	-$274K	0.02%	101
2016 Q2	$1.25M	Hold	222,981	–	–	0.02%	90
2016 Q1	$1.2M	Hold	222,981	–	–	0.02%	93
2015 Q4	$1.94M	Hold	222,981	–	–	0.03%	83
2015 Q3	$1.87M	Buy	222,981 +680	+0.3%	+$10.8K	0.03%	85
2015 Q2	$3.92M	Sell	222,301 -40,000	-15%	-$514K	0.06%	67
2015 Q1	$3.03M	Sell	262,301 -10,000	-4%	-$116K	0.04%	70
2014 Q4	$2.74M	Sell	272,301 -97,699	-26%	-$495K	0.04%	65
2014 Q3	$1.69M	Buy	+370,000	New	+$1.99M	0.02%	82

Other funds holding SRNE

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

C WorldWide Group's SRNE Position: Q4 2016 in Review

C WorldWide Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2016, closing a stake of 182,301 shares — an estimated $1.41M sold.

C WorldWide Group first reported a position in SRNE in Q3 2014 and held it in 9 quarters. The position peaked at $3.92M in Q2 2015. 68 funds tracked by Wall St. Rank hold SRNE as of Q4 2016.

C WorldWide Group reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
C WorldWide Group sold 182,301 Sorrento Therapeutics, Inc. shares in Q4 2016, an estimated $1.41M.
C WorldWide Group first reported a position in Sorrento Therapeutics, Inc. in Q3 2014 and held it in 9 quarters.
C WorldWide Group's Sorrento Therapeutics, Inc. position peaked at $3.92M in Q2 2015.
68 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2016.

Based on C WorldWide Group's 13F filing for Q4 2016, filed 6 Feb 2017.